Viral modulation of cell death by inhibition of caspases

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 1, 2003, Pages 19-27

  Cassens, Uwe ^a   Lewinski, Grzegorz ^b   Samraj, Ajoy K ^c   Von Bernuth, Horst ^d   Baust, Heinrich ^e   Khazaie, Khashayarsha ^f   Los, Marek ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Municipal Hospital   (Poland)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Caspase; CrmA; Granzyme B; IAP; p35

Indexed keywords

CASPASE; CYTOKINE; GAMMA INTERFERON; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; PROTEIN P35; SERINE PROTEINASE INHIBITOR;

APOPTOSIS; CELL DEATH; CELL STRUCTURE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; IMMUNE SYSTEM; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN DEGRADATION; REVIEW;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CASPASES; CELL DEATH; CYSTEINE PROTEINASE INHIBITORS; HUMANS; LIPOPROTEINS; MODELS, MOLECULAR; SERPINS; VIRAL PROTEINS; VIRUSES;

EID: 0037275960     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. AFONSO C. L., TULMAN E. R., LU Z., OMA E., KUTISH G. F. and ROCK D. L. (1999): The genome of melanoplus sanguinipes entomopoxvirus. J. Virol., 73, 533-552.
2. BAWDEN A. L., GLASSBERG K. J., DIGGANS J., SHAW R., FARMERIE W. and MOYER R. W. (2000): Complete genomic sequence of the Amsacta Moorei entomopoxvirus: analysis and comparison with other poxviruses. Virology, 274, 120-139.
3. BIRNBAUM M. J., CLEM R. J. and MILLER L. K. (1994): An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J. Virol., 68, 2521-2528.
4. BLANCHARD H., KODANDAPANI L., MITTL P. R., MARCO S. D., KREBS J. F., WU J. C., TOMASELLI K. J. and GRUTRER M. G. (1999): The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Structure Fold Des., 7, 1125-1133.
5. BODE W. and HUBER R. (1991): Proteinase-protein inhibitor interaction. Biomed. Biochim. Acta, 50, 437-446.
6. BOUDREAU N., SYMPSON C. J., WERB Z. and BISSELL, M. J. (1995): Suppression of ICE and apoptosis in mammary epithelial cells by extracellular. matrix. Science, 267, 891-893.
7. BUMP N. J., HACKETT M., HUGUNIN M., SESHAGIRI S., BRADY K., CHEN P., FERENZ C., FRANKLIN S., GHAYUR T., LI P., LICA-RI P., MANKOVITCH J., SHI L., GREENBERG A. H., MILLER L. K. and WONG W. W. (1995): Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science, 269, 1885-1888.
8. CHEN P., TIAN J., KOVESDI I. and BRUDER J. T. (1998): Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J. Biol. Chem., 273, 5815-5820.
9. CHLICHLIA K., LOS M., SCHULZE-OSTHOFF K., GAZZOLO L., SCHIRRMACHER V. and KHAZAIE K. (2002): Redox events in HTLV-1 TAX-induced apoptotic T-cell death. Antioxid. Redox Signal., 4, 471-477.
10. CHOU J. J., MATSUO H., DUAN H. and WAGNER G. (1998): Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell, 94, 171-180.
11. CLEM R. J. (2001): Baculoviruses and apoptosis: the good, the bad, and the ugly. Cell Death Differ., 8, 137-143.
12. CROOK N. E., CLEM R. J. and MILLER L. K. (1993): An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol., 67, 2168-2174.
13. DEVERAUX Q. L., LEO E., STENNICKE H. R., WELSH K., SALVESEN G. S. and REED J. C. (1999): Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J., 18, 5242-5251.
14. DEVERAUX Q. L. and REED J. C. (1999): IAP family proteins-suppressors of apoptosis. Genes Dev., 13, 239-252.
15. DEVERAUX Q. L., ROY N., STENNICKE H. R., VAN ARSDALE T., ZHOU Q., SRINIVASULA S. M., ALNEMRI E. S., SALVESEN G. S. and REED J. C. (1998): IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J., 17, 2215-2223.
16. DUCKETT C. S., NAVA V. E., GEDRICH R. W., CLEM R. J., VAN DONGEN J. L., GILFILLAN M. C., SHIELS H., HARDWICK J. M. and THOMPSON C. B. (1996): A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J., 15, 2685-2694.
17. EKERT P. G., SILKE J. and VAUX D. L. (1999): Caspase inhibitors. Cell Death Differ., 6, 1081-1086.
18. EVERETT H. and MCFADDEN G. (2001): Viruses and apoptosis: meddling with mitochondria. Virology, 288, 1-7.
19. FISHER A. J., CRUZ W., ZOOG S. J., SCHNEIDER C. L. and FRIESEN P. D. (1999): Crystal structure of baculovirus p35: role of a novel reactive site loop in apoptotic caspase inhibition. EMBO J., 18, 2031-2039.
20. FREEMONT P. S., HANSON I. M. and TROWSDALE J. (1991): A novel cysteine-rich sequence motif. Cell, 64, 483-484.
21. GETTINS P., PATSTON P. A. and SCHAPIRA M. (1993): The role of conformational change in serpin structure and function. Bioessays, 15, 461-467.
22. GHAYUR T., BANERJEE S., HUGUNIN M., BUTLER D., HERZOG L., CARTER A., QUINTAL L., SEKUT L., TALANIAN R., PASKIND M., WONG W., KAMEN R., TRACEY D. and ALLEN H. (1997): Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature, 386, 619-623.
23. GU Y., KUIDA K., TSUTSUI H., KU G., HSIAO K., FLEMING M. A., HAYASHI N., HIGASHINO K., OKAMURA H., NAKANISHI K., KURIMOTO M., TANIMOTO T., FLAVELL R. A., SATO V., HARDING M. W., LIVINGSTON D. J. and SU M. S. (1997): Activation of interferon-γ inducing factor mediated by interleukin 1β converting enzyme. Science, 275, 206-209.
24. HAUSER H. P., BARDROFF M., PYROWOLAKIS G. and JENTSCH S. (1998): A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J. Cell Biol., 141, 1415-1422.
25. HAWKINS C. J., YOO S. J., PETERSON E. P., WANG S. L., VERNOOY S. Y. and HAY B. A. (2000): The Drosophila caspase DRONC cleaves following glutamate or aspartate and is regulated by DIAP1, HID, and GRIM. J. Biol. Chem., 275, 27084-27093.
26. HAY B. A., WOLFF T. and RUBIN G. M. (1994): Expression of baculovirus p35 prevents cell death in Drosophila. Development, 120, 2121-2129.
27. HINDS M. G., NORTON R. S., VAUX D. L. and DAY C. L. (1999): Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat. Struct. Biol., 6, 648-651.
28. HU F. Q., SMITH C. A. and PICKUP D. J. (1994): Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology, 204, 343-356.
29. HUANG Y., PARK Y. C., RICH R. L., SEGAL D., MYSZKA D. G. and WU H. (2001): Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell, 104, 781-790.
30. HUBER R. and CARRELL R. W. (1989): Implications of the three-dimensional structure of α 1-antitrypsin for structure and function of serpins. Biochemistry, 28, 8951-8966.
31. IZQUIERDO M., GRANDIEN A., CRIADO L. M., ROBLES S., LEONARDO E., ALBAR J. P., DE BUITRAGO G. G. and MARTINEZ A. C. (1999): Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor. EMBO J., 18, 156-166.
32. JAKOB N. J., MULLER K., BAHR U. and DARAI G. (2001): Analysis of the first complete DNA sequence of an invertebrate iridovirus: coding strategy of the genome of Chilo iridescent virus. Virology, 286, 182-196.
33. KOMIYAMA T., QUAN L. T. and SALVESEN G. S. (1996): Inhibition of cysteine and serine proteinases by the cowpox virus serpin Crma. Adv. Exp. Med. Biol., 389, 173-176.
34. KOONIN E. V. and ARAVIND L. (2000): The nacht family a new group of predicted ntpases implicated in apoptosis and mhc transcription activation. Trends Biochem. Sci., 25, 223-224.
35. KRAMMER P. H. (2000): CD95's deadly mission in the immune system. Nature, 407, 789-795.
36. LACOUNT D. J., HANSON S. F., SCHNEIDER C. L. and FRIESEN P. D. (2000): Caspase inhibitor p35 and inhibitor of apoptosis Op-IAP block in vivo proteolytic activation of an effector caspase at different steps. J. Biol. Chem., 275, 15657-15664.
37. LAMKANFI M., DECLERCQ W., KALAI M., SAELENS X. and VANDENABEELE P. (2002): Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ., 9, 358-361.
38. LIN G., LI G., GRANADOS R. R. and BLISSARD G. W. (2001): Stable cell lines expressing baculovirus p35: resistance to apoptosis and nutrient stress, and increased glycoprotein secretion. In Vitro Cell Dev. Biol. Anim., 37, 293-302.
39. LISTON P., ROY N., TAMAI K., LEFEBVRE C., BAIRD S., CHERTON-HORVAT G., FARAHANI R., MCLEAN M., IKEDA J.-E., MACKENZIE A. and KORNELUK R. G. (1996): Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature, 379, 349-353.
40. LOS M., KHAZAIE K., SCHULZE-OSTHOFF K., BAEUERLE P. A., SCHIRRMACHER V. and CHLICHLIA K. (1998): Human T cell leukemia virus-I (HTLV-I) TAX-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state. J. Immunol., 161, 3050-3055.
41. LOS M., MOZOLUK M., FERRARI D., STEPCZYNSKA A., STROH C., RENZ A., HERCEG Z., WANG Z. Q. and SCHULZE-OSTHOFF K. (2002): Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol. Biol. Cell, 13, 978-988.
42. LOS M., STROH C., JANICKE R. U., ENGELS I. H. and SCHULZE-OSTHOFF K. (2001): Caspases: more than just killers? Trends. Immunol., 22, 31-34.
43. LOS M., VAN DE CRAEN M., PENNING C. L., SCHENK H., WESTENDORP M., BAEUERLE P. A., DROGE W., KRAMMER P. H., FIERS W. and SCHULZE-OSTHOFF K. (1995): Requirement of an ICE/Ced-3 protease for Fas/Apo-1-mediated apoptosis. Nature, 371, 81-83.
44. LOS M., WALCZAK H., SCHULZE-OSTHOFF K. and REED J. C. (2000): Fluorogenic substrates as detectors of caspase activity during natural killer cell-induced apoptosis. Methods Mol. Biol., 121, 155-162.
45. LoS M., WESSELBORG S. and SCHULZE-OSTHOFF K. (1999): The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity, 10, 629-639.
46. MACEN J. L., GARNER R. S., MUSY P. Y., BROOKS M. A., TURNER P. C., MOYER R. W., MCFADDEN G. and BLEACKLEY R. C. (1996): Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc. Natl. Acad. Sci. USA, 93, 9108-9113.
47. MACEN J., TAKAHASHI A., MOON K. B., NATHANIEL R., TURNER P. C. and MOYER R. W. (1998): Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses. J. Virol., 72, 3524-3533.
48. MAGUIRE T., HARRISON P., HYINK O., KALMAKOFF J. and WARD V. K. (2000): The inhibitors of apoptosis of Epiphyas postvittana nucleopolyhedrovirus. J. Gen. Virol., 81, 2803-2811.
49. MANJI G. A. and FRIESEN P. D. (2001): Apoptosis in motion. An apical, p35-insensitive caspase mediates programmed cell death in insect cells. J. Biol. Chem., 276, 16704-16710.
50. MICHALKE M., STROH C., CHLICHLIA C., STEPCZYNSKA A., MOZOLUK M. and LOS M. (2001): The emerging role of caspases in signal transduction as revealed by knock-out studies - not only apoptosis. Signal Transd., 2, 51-65.
51. MITTL P. R., DI MARCO S., KREBS J. F., BAI X., KARANEWSKY D. S., PRIESTLE J. P., TOMASELLI K. J. and GRUTTER M. G. (1997): Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J. Biol. Chem., 272, 6539-6547.
52. MIURA M., ZHU H., ROTELLO R., HARTWIEG E. A. and YUAN J. (1993): Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75, 653-660.
53. MULLBACHER A., WARING P., THA HLA R., TRAN T., CHIN S., STEHLE T., MUSETEANU C. and SIMON M. M. (1999): Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl. Acad. Sci. USA., 96, 13950-13955.
54. NEILAN J. G., LU Z., KUTISH G. F., ZSAK L., BURRAGE T. G., BORCA M. V., CARRILLO C. and ROCK D. L. (1997): A BIR motif containing gene of African swine fever virus, 4CL, is nonessential for growth in vitro and viral virulence. Virology, 230, 252-264.
55. NOGAL M. L., GONZALEZ DE BUITRAGO G., RODRIGUEZ C., CUBELOS B., CARRASCOSA A. L., SALAS M. L. and REVILLA Y. (2001): African swine fever virus IAP homologue inhibits caspase activation and promotes cell survival in mammalian cells. J. Virol., 75, 2535-2543.
56. PICKUP D. J., INK B. S., HU W., RAY C. A. and JOKLIK W. K. (1986): Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc. Natl. Acad. Sci. USA, 83, 7698-7702.
57. QIN H., SRINIVASULA S. M., WU G., FERNANDES-ALNEMRI T., ALNEMRI E. S. and SHI Y. (1999): Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature, 399, 549-557.
58. QUAN L. T., CAPUTO A., BLEACKLEY R. C., PICKUP D. J. and SALVESEN G. S. (1995): Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem., 270, 10377-10379.
59. RAWLINGS N. D. (1998): Handbook of proteolytic enzymes. Academic Press, San Diego, CA.
60. RAY C. A., BLACK R. A., KRONHEIM S. R., GREENSTREET T. A., SLEATH P. R., SALVESEN G. S. and PICKUP D. J. (1992): Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell, 69, 597-604.
61. RAY C. A. and PICKUP D. J. (1996): The mode of death of pig kidney cells infected with cowpox virus is governed by the expression of the crma gene. Virology, 217, 384-391.
62. RENATUS M., ZHOU Q., STENNICKE H. R., SNIPAS S. J., TURK D., BANKSTON L. A., LIDDINGTON R. C. and SALVESEN G. S. (2000): Crystal structure of the apoptotic suppressor CrmA in its cleaved form. Structure Fold Des., 8, 789-797.
63. RENZ A., BERDEL W. E., KREUTER M., BELKA C., SCHULZE-OSTHOFF K. and LOS M. (2001): Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood, 98, 1542-1548.
64. RENZ A., BUREK C., MIER W., MOZOLUK M., SCHULZE-OSTHOFF K. and LOS M. (2001): Cytochrome c is rapidly extruded from apoptotic cells and detectable in serum of anticancer-drug treated tumor patients. Adv. Exp. Med. Biol., 495, 331-334.
65. RIEDL S. J., RENATUS M., SCHWARZENBACHER R., ZHOU Q., SUN C., FESIK S. W., LIDDINGTON R. C. and SALVESEN G. S. (2001): Structural basis for the inhibition of caspase-3 by XIAP. Cell, 104, 791-800.
66. RIEDL S. J., RENATUS M., SNIPAS S. J. and SALVESEN G. S. (2001): Mechanism-based inactivation of caspases by the apoptotic suppressor p35. Biochemistry, 40, 13274-13280.
67. ROTONDA J., NICHOLSON D. W., FAZIL K. M., GALLANT M., GAREAU Y., LABELLE M., PETERSON E. P., RASPER D. M., RUEL R., VAILLANCOURT J. P., THORNBERRY N. A. and BECKER J. W. (1996): The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol., 3, 619-625.
68. ROY N., DEVERAUX Q. L., TAKAHASHI R., SALVESEN G. S. and REED J. C. (1997): The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J., 16, 6914-6925.
69. SADOWSKI-DEBBING K., COY J. F., MIER W., HUG H. and LOS M. (2002): Caspases - their role in apoptosis and other physiological processes as revealed by knock-out studies. Arch. Immunol. Ther. Exp., 50, 19-34.
70. SALVESEN G. S. and DIXIT V. M. (1997): Caspases: intracellular signaling by proteolysis. Cell, 91, 443-446.
71. SILVERMAN G. A., BIRD P. I., CARRELL R. W., CHURCH F. C., COUGHLIN P. B., GETTINS P. G., IRVING J. A., LOMAS D. A., LUKE C. J., MOYER R. W., PEMBERTON P. A., REMOLD-O'DONNELL E., SALVESEN G. S., TRAVIS J. and WHISSTOCK J. C. (2001): The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem., 276, 33293-33296.
72. SIMONOVIC M., GETTINS P. G. W. and VOLZ K. (2000): Crystal structure of viral serpin CrmA provides insights into its mechanism of cysteine proteinase inhibition. Protein Sci., 9, 1423-1427.
73. SKALETSKAYA A., BARTLE L. M., CHITTENDEN T., MCCORMICK A. L., MOCARSKI E. S. and GOLDMACHER V. S. (2001): A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA, 98, 7829-7834.
74. STENNICKE H. R., RYAN C. A. and SALVESEN G. S. (2002): Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem. Sci., 27, 94-101.
75. STENNICKE H. R. and SALVESEN G. S. (1999): Catalytic properties of the caspases. Cell Death Differ., 6, 1054-1059.
76. SUN X. M., MACFARLANE M., ZHUANG J., WOLF B. B., GREEN D. R, and COHEN G. M. (1999): Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem., 274, 5053-5060.
77. TAKAHASHI A., HIRATA H., YONEHARA S., IMAI Y., LEE K. K., MOYER R. W., TURNER P. C., MESNER P. W., OKAZAKI T., SAWAI H., KISHI S., YAMAMOTO K., OKUMA M. and SASADA M. (1997): Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene, 14, 2741-2752.
78. TAKAHASHI R., DEVERAUX Q., TAMM I., WELSH K., ASSA-MUNT N., SALVESEN G. S. and REED J. C. (1998): A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem., 273, 7787-7790.
79. THORNBERRY N. A., RANO T. A., PETERSON E. P., RASPER D. M., TIMKEY T., GARCIA CALVO M., HOUTZAGER V. M., NORDSTROM P. A., ROY S., VAILLANCOURT J. P., CHAPMAN K. T. and NICHOLSON D. W. (1997): A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem., 272, 17907-17911.
80. VERDECIA M. A., HUANG H., DUTIL E., KAISER D. A., HUNTER T. and NOEL J. P. (2000): Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol., 7, 602-608.
81. VIER J., FURMANN C. and HACKER G. (2000): Baculovirus p35 protein does not inhibit caspase-9 in a cell-free system of apoptosis. Biochem. Biophys. Res. Commun., 276, 855-861.
82. WALCZAK H. and KRAMMER P. H. (2000): The CD95 (APO-1/Fas) and the trail (APO-2L) apoptosis systems. Exp. Cell Res., 256, 58-66.
83. WALKER N. P., TALANIAN R. V., BRADY K. D., DANG L. C., BUMP N. J., FERENZ C. R., FRANKLIN S., GHAYUR T., HACKETT M. C. and HAMMILL L. D. (1994): Crystal structure of the cysteine protease interleukin-1β-converting enzyme: a (p20/p10)2 homodimer. Cell, 78, 343-352.
84. WEI Y., Fox T., CHAMBERS S. P., SINTCHAK J., COLL J. T., GOLEC J. M., SWENSON L., WILSON K. P. and CHARIFSON P. S. (2000): The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem. Biol., 7, 423-432.
85. WESTENDORP M. O., FRANK R., OCHSENBAUER C., STRICKER K., DHEIN J., WALCZAK H., DEBATIN K. M. and KRAMMER P. H. (1995): Sensitization of T cells to CD95-mediated apoptosis by HIV-1 TAT and gp120. Nature, 375, 497-500.
86. 1-antitrypsin. J. Mol. Biol., 295, 651-665.
87. WILSON K. P., BLACK J.-A. F., THOMSON J. A., KIM E. E., GRIFFITH J. P., NAVIA M. A., MURCKO M. A., CHAMBERS S. P., ALDAPE R. A., RAYBUCK S. A, and LIVINGSTON D. J. (1994): Structure and mechanism of interleukin-1β converting enzyme. Nature, 370, 270-275.
88. XU G., CIRILLI M., HUANG Y., RICH R. L., MYSZKA D. G. and WU H. (2001): Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature, 410, 494-497.
89. XUE D. and HORVlTZ H. R. (1995): Inhibition of the Caenorhabditis elegans cell-death protease Ced-3 by a Ced-3 cleavage site in baculovirus p35 protein. Nature, 377, 248-251.
90. YANG Y., FANG S., JENSEN J. P., WEISSMAN A. M. and ASHWELL J. D. (2000): Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science, 288, 874-877.
91. ZHENG T. S. and FLAVELL R. A. (2000): Divinations and surprises: genetic analysis of caspase function in mice. Exp. Cell. Res., 256, 67-73.
92. ZHOU Q., SNIPAS S., ORTH K., MUZIO M., DIXIT V. M. and SALVESEN G. S. (1997): Target protease specificity of the viral serpin crmA. Analysis of five caspases. J. Biol. Chem., 272, 7797-7800.
93. ZOOG S. J., BERTIN J. and FRIESEN P. D. (1999): Caspase inhibition by baculovirus p35 requires interaction between the reactive site loop and the β-sheet core. J. Biol. Chem., 274, 25995-26002.